Pfizer will study the effectiveness of its vaccine against COVID-19 by inoculating the whole population over the age of 12 in a town in southern Brazil, the company said on Wednesday.
The study will be conducted in Toledo, population 143,000, in the west of Parana state, together with Brazil's National Vaccination Program, local health authorities, a hospital and the federal university.
Pfizer said the purpose was to study the behaviour of COVID-19 in a "real life scenario" after the population has been vaccinated.
"The initiative is the first and only of its kind to be undertaken in a developing country in collaboration with the pharmaceutical company," it added.
UN rights chief says uncovered remains in Gaza raise concerns of war crimes
Indian police to query Google over 500,000 fake Gmail IDs linked to bomb hoax
Saudi Arabia says danger passed in six cities, including Yanbu
Bahrain, Kuwait, Jordan offer condolences over martyrdom of two UAE servicemen
